Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Company announcement – No. 22 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL)…
Zealand Pharma - Transactions related to share buy-back program (week 23, 2026)
Company announcement No. 23 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 23, 2026) Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026
10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) ranks #5 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller). Druckenmiller's Stake:…
Stock Movers: Monte Dei Paschi, Tate & Lyle, Zealand Pharma
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…
India ready to open pharma market to innovative global products: Goyal
India is willing to open its market to high-quality and innovative products from the global pharma sector in return for preferential access for the domestic drug exports, Commerce and Industry Minister Piyush Goyal said on Monday. He said that the…
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved…
After IAP exit, Hyderabad paediatrician Sivaranjani Santosh alleges pharma influence, seeks probe into ORSL promotion
Hyderabad-based paediatrician Dr Sivaranjani Santosh has said that her resignation from the Indian Academy of Paediatrics (IAP), which she submitted nearly two months ago, has now been formally accepted by the organisation. In a post on social…
Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)
SEOUL, South Korea, June 7, 2026 /CNW/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive topline results from its Phase II randomized…
Lupin partners with Spanish pharma company Laboratorios ERN on respiratory drug, for Spain
Lupin Limited is partnering with Spanish pharma company Laboratorios ERN SA to launch its fixed dose combination Luforbec (beclometasone/formoterol), in Spain. The drug, administered through a pressurized metered dose inhaler (pMDI), is used to…
Royalty Pharma (NASDAQ:RPRX) Hits New 52-Week High - Time to Buy?
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) reached a new 52-week high during trading on Monday. The company traded as high as $56.29 and last traded at $56.3110, with a volume of 2862 shares traded. The stock had previously closed at…
Royalty Pharma PLC $RPRX Stock Position Increased by Brandywine Global Investment Management LLC
Brandywine Global Investment Management LLC raised its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 4.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm…
The 'New' New Way To Sell Prescription Medications
Adam Wolfberg, MD, is chief medical officer at Virta Health, where he leads a clinical team focused on treatment of diabetes and obesity. The fastest, least-expensive way to find a doctor who will prescribe Zepbound for weight loss may be…
Capital International Ltd. CA Sells 4,811 Shares of Ascendis Pharma A/S $ASND
Capital International Ltd. CA trimmed its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 22.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 16,861 shares of the biotechnology…
Capital International Inc. CA Acquires 58,030 Shares of Royalty Pharma PLC $RPRX
Capital International Inc. CA raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 8.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The…
Stock Markets Tumble: West Asia Tensions, Oil Prices, and Global Sell-Off Impact Indian Equities
Indian stock markets, including the Sensex and Nifty, plunged in early trade amidst a sharp global equities decline, a fresh surge in crude oil prices due to escalating West Asia tensions, and a significant unwinding of the global AI-led rally.
Receive a Daily briefing on Pharma Industry News
Get Started